Integrated phosphoproteomic and metabolomic profiling reveals perturbed pathways in the hippocampus of gut microbiota dysbiosis mice
Authors:
Open Access
- 13 October 2020
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 10 (1) , 1-12
Abstract
The dysbiosis of gut microbiota is an important environmental factor that can induce mental disorders, such as depression, through the microbiota–gut–brain axis. However, the underlying pathogenic mechanisms are complex and not completely understood. Here we utilized mass spectrometry to identify the global phosphorylation dynamics in hippocampus tissue in germ-free mice and specific pathogen-free mice (GF vs SPF), fecal microbiota transplantation (FMT) model (“depression microbiota” and the “healthy microbiota” recipient mice). As a result, 327 phosphosites of 237 proteins in GF vs SPF, and 478 phosphosites of 334 proteins in “depression microbiota” vs “healthy microbiota” recipient mice were identified as significant. These phosphorylation dysregulations were consistently associated with glutamatergic neurotransmitter system disturbances. The FMT mice exhibited disturbances in lipid metabolism and amino acid metabolism in both the periphery and brain through integrating phosphoproteomic and metabolomic analysis. Moreover, CAMKII-CREB signaling pathway, in response to these disturbances, was the primary common perturbed cellular process. In addition, we demonstrated that the spliceosome, never directly implicated in mental disorders previously, was a substantially neuronal function disrupted by gut microbiota dysbiosis, and the NCBP1 phosphorylation was identified as a novel pathogenic target. These results present a new perspective to study the pathologic mechanisms of gut microbiota dysbiosis related depression and highlight potential gut-mediated therapies for depression.Keywords
This publication has 68 references indexed in Scilit:
- Host Remodeling of the Gut Microbiome and Metabolic Changes during PregnancyCell, 2012
- Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic functionEuropean Archives of Psychiatry and Clinical Neuroscience, 2012
- Towards a glutamate hypothesis of depressionNeuropharmacology, 2012
- Dysfunctional gene splicing as a potential contributor to neuropsychiatric disordersAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2011
- The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophreniaMolecular Psychiatry, 2009
- Human Protein Reference Database--2009 updateNucleic Acids Research, 2008
- STRING 8--a global view on proteins and their functional interactions in 630 organismsNucleic Acids Research, 2008
- Innate immunity and intestinal microbiota in the development of Type 1 diabetesNature, 2008
- Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathwayJournal of Cell Biology, 2008
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006